【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 10
2 Introduction 11
2.1 Pancreatic Cancer Overview 11
3 Products under Development 12
3.1 Pancreatic Cancer – Pipeline Products by Stage of Development 12
3.2 Pancreatic Cancer – Pipeline Products by Territory 13
3.3 Pancreatic Cancer – Pipeline Products by Regulatory Path 14
3.4 Pancreatic Cancer – Pipeline Products by Estimated Approval Date 15
4 Pancreatic Cancer – Pipeline Products under Development by Companies 16
4.1 Pancreatic Cancer Companies – Pipeline Products by Stage of Development 16
4.2 Pancreatic Cancer – Pipeline Products by Stage of Development 19
5 Pancreatic Cancer Companies and Product Overview 21
5.1 A&G Pharmaceutical, Inc. Company Overview 21
5.1.1 A&G Pharmaceutical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 21
5.2 Abcodia Ltd. Company Overview 23
5.2.1 Abcodia Ltd. Pipeline Products & Ongoing Clinical Trials Overview 23
5.3 Acobiom Company Overview 24
5.3.1 Acobiom Pipeline Products & Ongoing Clinical Trials Overview 24
5.4 Andraka Technologies, LLC Company Overview 25
5.4.1 Andraka Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 25
5.5 Applied Proteomics, Inc. Company Overview 26
5.5.1 Applied Proteomics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 26
5.6 Asuragen, Inc. Company Overview 27
5.6.1 Asuragen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 27
5.7 BioMarker Strategies, LLC Company Overview 28
5.7.1 BioMarker Strategies, LLC Pipeline Products & Ongoing Clinical Trials Overview 28
5.8 Biouniversa s.r.l. Company Overview 29
5.8.1 Biouniversa s.r.l. Pipeline Products & Ongoing Clinical Trials Overview 29
5.9 Cancer Research Technology Limited Company Overview 31
5.9.1 Cancer Research Technology Limited Pipeline Products & Ongoing Clinical Trials Overview 31
5.10 Cellmid Limited Company Overview 32
5.10.1 Cellmid Limited Pipeline Products & Ongoing Clinical Trials Overview 32
5.11 Cepheid Company Overview 33
5.11.1 Cepheid Pipeline Products & Ongoing Clinical Trials Overview 33
5.12 Chronix Biomedical, Inc. Company Overview 35
5.12.1 Chronix Biomedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 35
5.13 Cleveland Diagnostics Inc. Company Overview 37
5.13.1 Cleveland Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview 37
5.14 Clovis Oncology, Inc. Company Overview 38
5.14.1 Clovis Oncology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 38
5.15 CompanDX Ltd. Company Overview 40
5.15.1 CompanDX Ltd. Pipeline Products & Ongoing Clinical Trials Overview 40
5.16 Courtagen Life Sciences, Inc. Company Overview 41
5.16.1 Courtagen Life Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 41
5.17 CS-Keys, Inc. Company Overview 42
5.17.1 CS-Keys, Inc. Pipeline Products & Ongoing Clinical Trials Overview 42
5.18 Dartmouth College Company Overview 43
5.18.1 Dartmouth College Pipeline Products & Ongoing Clinical Trials Overview 43
5.19 Di.V.A.L Toscana srl Company Overview 45
5.19.1 Di.V.A.L Toscana srl Pipeline Products & Ongoing Clinical Trials Overview 45
5.20 Exact Sciences Corporation Company Overview 46
5.20.1 Exact Sciences Corporation Pipeline Products & Ongoing Clinical Trials Overview 46
5.21 GeneFluidics Inc. Company Overview 48
5.21.1 GeneFluidics Inc. Pipeline Products & Ongoing Clinical Trials Overview 48
5.22 German Cancer Research Center Company Overview 49
5.22.1 German Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview 49
5.23 GlycoZym Company Overview 50
5.23.1 GlycoZym Pipeline Products & Ongoing Clinical Trials Overview 50
5.24 Health Discovery Corporation Company Overview 51
5.24.1 Health Discovery Corporation Pipeline Products & Ongoing Clinical Trials Overview 51
5.25 Hebrew University of Jerusalem Company Overview 53
5.25.1 Hebrew University of Jerusalem Pipeline Products & Ongoing Clinical Trials Overview 53
5.26 ImmunoCellular Therapeutics, Ltd. Company Overview 54
5.26.1 ImmunoCellular Therapeutics, Ltd. Pipeline Products & Ongoing Clinical Trials Overview 54
5.27 Immunomedics, Inc. Company Overview 56
5.27.1 Immunomedics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 56
5.28 Imperial College London Company Overview 58
5.28.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 58
5.29 IV Diagnostics, Inc. Company Overview 59
5.29.1 IV Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 59
5.30 Matrix-Bio, Inc. Company Overview 60
5.30.1 Matrix-Bio, Inc. Pipeline Products & Ongoing Clinical Trials Overview 60
5.31 Mayo Clinic Company Overview 61
5.31.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 61
5.32 MDNA Life Sciences, Inc. Company Overview 62
5.32.1 MDNA Life Sciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 62
5.33 Merrimack Pharmaceuticals, Inc. Company Overview 63
5.33.1 Merrimack Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview 63
5.34 Metanomics Health GmbH Company Overview 65
5.34.1 Metanomics Health GmbH Pipeline Products & Ongoing Clinical Trials Overview 65
5.35 Milagen, Inc. Company Overview 66
5.35.1 Milagen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 66
5.36 Miraculins Inc. Company Overview 67
5.36.1 Miraculins Inc. Pipeline Products & Ongoing Clinical Trials Overview 67
5.37 NanoScale Corporation Company Overview 69
5.37.1 NanoScale Corporation Pipeline Products & Ongoing Clinical Trials Overview 69
5.38 NatiMab Therapeutics S.r.l. Company Overview 70
5.38.1 NatiMab Therapeutics S.r.l. Pipeline Products & Ongoing Clinical Trials Overview 70
5.39 National Cheng-Kung University Hospital Company Overview 71
5.39.1 National Cheng-Kung University Hospital Pipeline Products & Ongoing Clinical Trials Overview 71
5.40 Neogenix Oncology, Inc. Company Overview 72
5.40.1 Neogenix Oncology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 72
5.41 Onconome, Inc. Company Overview 73
5.41.1 Onconome, Inc. Pipeline Products & Ongoing Clinical Trials Overview 73
5.42 OPKO Health, Inc. Company Overview 75
5.42.1 OPKO Health, Inc. Pipeline Products & Ongoing Clinical Trials Overview 75
5.43 Oxford Gene Technology Limited Company Overview 77
5.43.1 Oxford Gene Technology Limited Pipeline Products & Ongoing Clinical Trials Overview 77
5.44 PeriRx LLC Company Overview 78
5.44.1 PeriRx LLC Pipeline Products & Ongoing Clinical Trials Overview 78
5.45 Precision Biologics, Inc. Company Overview 79
5.45.1 Precision Biologics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 79
5.46 Proplex Technologies, Llc Company Overview 80
5.46.1 Proplex Technologies, Llc Pipeline Products & Ongoing Clinical Trials Overview 80
5.47 Protagen AG Company Overview 82
5.47.1 Protagen AG Pipeline Products & Ongoing Clinical Trials Overview 82
5.48 SDIX, LLC Company Overview 83
5.48.1 SDIX, LLC Pipeline Products & Ongoing Clinical Trials Overview 83
5.49 Sienna Cancer Diagnostics Ltd Company Overview 85
5.49.1 Sienna Cancer Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 85
5.50 SomaLogic, Inc. Company Overview 86
5.50.1 SomaLogic, Inc. Pipeline Products & Ongoing Clinical Trials Overview 86
5.51 Source MDx Company Overview 87
5.51.1 Source MDx Pipeline Products & Ongoing Clinical Trials Overview 87
5.52 Stanford University Company Overview 88
5.52.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 88
5.53 The Johns Hopkins University Company Overview 89
5.53.1 The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 89
5.54 Thomas Jefferson University Company Overview 93
5.54.1 Thomas Jefferson University Pipeline Products & Ongoing Clinical Trials Overview 93
5.55 US Biomarkers, Inc. Company Overview 94
5.55.1 US Biomarkers, Inc. Pipeline Products & Ongoing Clinical Trials Overview 94
5.56 Viomics Inc. Company Overview 95
5.56.1 Viomics Inc. Pipeline Products & Ongoing Clinical Trials Overview 95
5.57 Vitatex Inc. Company Overview 96
5.57.1 Vitatex Inc. Pipeline Products & Ongoing Clinical Trials Overview 96
5.58 VolitionRX Ltd. Company Overview 98
5.58.1 VolitionRX Ltd. Pipeline Products & Ongoing Clinical Trials Overview 98
6 Pancreatic Cancer- Recent Developments 100
7 Appendix 104
7.1 Methodology 104
7.2 About GlobalData 106
7.3 Contact Us 107
7.4 Disclaimer 107
【レポート販売概要】
■ タイトル：世界における膵臓癌検査製品のパイプライン動向2015■ 英文：Pancreatic Cancer - Pipeline Review, 2015
■ 発行日：2015年10月1日
■ 調査会社：GlobalData
■ 商品コード：GDME0072EPD
■ 調査対象地域：グローバル
- エンドウ豆タンパクの世界市場2016-2020About the Pea Protein Market Pea protein is extracted from yellow peas, known as Pisum sativum, and has a typical legume amino acid profile. Being highly nutritive and functional, pea protein has gained a strong foothold in the plant-based protein market. It is also a clean-label product with non-allergic attributes and is a viable alternative to eggs and is therefore used in a variety of bakery a …
- Raynauds Disease：グローバル臨床試験レビューH2, 2013Raynauds Disease Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Raynauds Disease Global Clinical Trials Review, H2, 2013" provides data on the Raynauds Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Raynauds Disease. It includes an overview of the trial numbers and their recruitment statu …
- デジタルマップ（電子地図）の世界市場2015-2019About digital maps Digital mapping is a process by which data is collected and compiled to form a virtual image. The data compiled is used to produce maps that accurately represent a particular geographical area or feature, including major roads, rivers, and important landmarks such as airports, tourist attractions, and hospitals. Digital mapping technology also provides an option to calculate the …
- Eコマースロジスティクスの世界市場2019-2023About this market Cross-border e-commerce involves a process by which customers purchase products from outside their borders. Cross-border e-commerce is significantly high in countries such as the US. China, Singapore, Indonesia, Australia, France, Mexico, and India. Customers in Australia buy clothes from online businesses outside their borders. Through cross-border e-commerce, sellers get the op …
- 小型ドローンの世界市場：軍用、商用、マイクロ、ミニ、ナノThe global small drones market is projected to grow from USD 5.80 Billion in 2015 to USD 10.04 Billion by 2020, at a CAGR of 11.6% during the forecast period. Factors such as rising demand for operational efficiency for surveillance and reconnaissance, and minimized human intervention in combat and other risky military operations and in commercial avenues, such as agriculture and transportation fo …
- 産業用真空ポンプの世界市場2016-2020About the Industrial Vacuum Pump Market Vacuum pumps are used to remove gas molecules from a sealed space or enclosure or a package. Despite the emergence of solid state electronics, vacuum pumping technology has evolved and its application has grown significantly. This technology plays a central role in at least 70 general manufacturing uses such as compression and drying that cover a wide range …
- FieldPoint Petroleum Corporation：石油・ガスの開発・生産動向及びコスト分析– Q4, 2012FieldPoint Petroleum Corporation Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2012 Summary FieldPoint Petroleum Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report …
- 産業用通信の世界市場予測（～2023年）“Industrial communication market to grow at 11.14% CAGR during 2018–2023”The industrial communication market is expected to reach USD 83.2 billion by 2018 from USD 141.0 billion by 2023, at a CAGR of 11.14% during 2018–2023. The market is mainly driven by the adoption of Industrial Internet of Things (IIoT) and advancement in M2M communication technology for industrial networking. The growth of In …
- カンジダ症治療薬の世界市場2019-2023About this market Advances in diagnosis of antifungal resistant pathogens to drive market growth. Although the currently available antifungal drugs are killing various species of candidiasis, some fungi can develop the ability to defend these drugs. For instance, Candida auris, an emerging antifungal¬resistant yeast, is frequently resistant to multiple antifungal drugs that were used to treat Cand …
- デジタル電力計の世界市場2017-2021About Digital Power MeterDigital power meters are next-generation meters that provide precise readings of electricity consumption and are generally installed in households or in enterprises to maintain detailed statistics on energy consumption. Technavio’s analysts forecast the global digital power meter market to grow at a CAGR of 4.91% during the period 2017-2021. [Covered in this report] The re …
- 世界の工業用けい砂（Industrial Silica Sand）市場動向（2012-2016）TechNavio’s analysts forecast the Global Industrial Silica Sand market to grow at a CAGR of 4.50 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increased adoption of industrial silica sand for hydraulic fracturing. The Global Industrial Silica Sand market has also been witnessing the increasing focus toward R&D activities. However, increasing us …
- 世界の艦艇及び水上戦闘艦艇市場動向2013-2023：主な開発プロジェクトThis report discusses the various programmes conducted by key players in the market, by dividing them into the main types of Naval Vessels and Surface Combatants. The report offers detailed information regarding quantity procured, country/companies supplying the equipment, delivery period and total contract value.
- 世界のマイクロ波装置市場予測及び分析（2014 – 2019）：クライストロン、サイラトロン、進行波管などThe report provides an in-depth analysis of the global microwave devices market. It gives information about the various types of microwave tubes such as Klystron, Magnetron, TWT, and Thyratron with respect to geography, application, type, and the current market scenario. The global microwave devices market is expected to grow at a CAGR of 3.40% and reach $1.2 billion by 2019. The global microwave …
- おむつ交換台の世界市場2017-2021About Baby Changing Stations Market Baby changing stations provide a smooth surface that facilitates the changing of diapers. These stations are situated at a convenient position in public restrooms and home nurseries. Baby changing stations are of two types, which include horizontal baby changing stations and vertical baby changing stations. Baby changing stations are either made of steel or plas …
- モバイル決済の将来：世界経済危機期間中のコマース（The Future of Mobile Payments: Continuation of Commerce during Global Economic Crisis）The modern financial world has evolved from a relatively resilient system to one that is highly interconnected and subject to cascading failures. For example, global banks have become increasingly interconnected, which means that a failure in one bank can have ramifications for many more. There are many potential triggers that could cause a domino effect including sovereign default, changes in int …
